The Limit of Limits: India’s Hurdles in Regulating Antimicrobial Pollution

  04 May 2022

In this CIDRAP-ASP report, we analyze the events surrounding the proposal and eventual removal of the limits, describing the issue of antibiotic pollution in India within the larger context of pharmaceutical demand and outsourcing of manufacture from high-income countries (HICs), the role of India as a competitive and necessary source of pharmaceuticals during the COVID-19 pandemic, criticisms raised about the antibiotic waste limits from diverse viewpoints and interests, and potential next steps for ensuring that the issue of environmental pollution remains in the foreground of all discussion about antibiotic innovation and manufacture.

Further reading: CIDRAP
Author(s): Natalie Vestin, MPH
Clean Environment  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!